Can meditation change the brain in schizophrenia?

People living with schizophrenia often experience long‑term symptoms that affect thinking, perception and daily functioning. While medication remains essential, many people continue to have difficulties despite treatment. This has led researchers to explore whether additional approaches could help alongside standard care. 

A new randomised controlled trial published in the European Archives of Psychiatry and Clinical Neuroscience provides some of the strongest evidence yet that meditation may play a supportive role in this context. The study, led by Yang and colleagues and published on 19 May 2026, examined the effects of a structured meditation programme in people with chronic schizophrenia.

What did the researchers do?

Participants with long‑standing schizophrenia were randomly assigned either to a meditation‑based intervention or to a comparison condition. The meditation programme was structured and delivered alongside usual clinical care, rather than as a replacement for medication or other treatments. 

The researchers assessed changes in clinical symptoms and also used brain imaging to examine grey matter volume. This allowed them to look not only at how people felt and functioned, but also at whether there were measurable changes in the brain.

What did they find? 

People who took part in the meditation programme showed significant reductions in clinical symptoms compared with the control group. Importantly, these improvements were accompanied by detectable changes in grey matter volume. 

This combination of clinical and neurobiological findings is what makes the study stand out. While meditation has been explored previously in mental health, this trial provides unusually robust evidence linking a psychological intervention with measurable brain changes in a population with severe mental illness. 

The authors are careful to stress that meditation should be seen as an adjunctive treatment. Medication and clinical support remain central to care for schizophrenia. However, the findings suggest that structured meditation could offer additional benefits when integrated thoughtfully into existing treatment plans. 

Why does this matter? 

For people with chronic schizophrenia, treatment options can feel limited, particularly when symptoms persist despite medication. Research like this helps broaden the conversation about what supportive, evidence‑based care might look like. 

From a research perspective, the study also challenges assumptions that the adult brain in severe mental illness is fixed or unresponsive to non‑pharmacological interventions. Demonstrating changes in grey matter adds weight to the idea that psychological and behavioural approaches can have meaningful biological effects. 

As with all single studies, further research will be needed to replicate and extend these findings, and to understand who is most likely to benefit. But this trial represents an important step towards more integrated approaches to mental health care.